» Articles » PMID: 22677427

Hepatoid Pancoast Tumor. A Case Report and Review of the Literature

Overview
Journal Lung Cancer
Specialty Oncology
Date 2012 Jun 9
PMID 22677427
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

A 48-year-old male patient presented with a Pancoast tumor of the right lung and a serum alpha-fetoprotein (αFP) at 39,000 ng/ml. Alpha-fetoprotein is a tumor marker found elevated in patients with hepatocellular carcinoma (HCC), germ cell or stromal tumors of the ovary and nonseminomatous testicular cancer. Occasionally, this tumor marker may rise in non-neoplastic conditions such as cirrhosis and hepatitis and only exceptionally in rare cancers with hepatoid differentiation. We present our case report and review the English literature for αFP-producing lung carcinomas. To the best of our knowledge this is the first report in the literature of an αFP producing Pancoast tumor.

Citing Articles

Primary hepatoid adenocarcinoma of the lung with extremely elevated serum AFP: a case report and literature review.

Cai C, Zhang N, Wang M, Wang L, Zhao H, Zhang X Front Oncol. 2024; 14:1448219.

PMID: 39421450 PMC: 11484443. DOI: 10.3389/fonc.2024.1448219.


Optimal treatment strategies for hepatoid adenocarcinoma of the lung: insights from a comprehensive analysis.

Deng H, Wang L, Li Z, Zhan T, Huang L BMC Cancer. 2024; 24(1):948.

PMID: 39095810 PMC: 11297620. DOI: 10.1186/s12885-024-12682-z.


A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.

Xu K, Gao J, Feng L, Fang Y, Tang X Front Immunol. 2023; 14:1203876.

PMID: 37292208 PMC: 10244673. DOI: 10.3389/fimmu.2023.1203876.


Hepatoid Adenocarcinoma of the Lung: A Review of the Most Updated Literature and a Presentation of Three Cases.

Bonis A, DellAmore A, Verzeletti V, Melan L, Zambello G, Nardocci C J Clin Med. 2023; 12(4).

PMID: 36835946 PMC: 9964907. DOI: 10.3390/jcm12041411.


Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.

Xu S, Zhang X, Jiang Q, Chen M, He M, Shen P World J Clin Cases. 2022; 10(28):10236-10243.

PMID: 36246828 PMC: 9561556. DOI: 10.12998/wjcc.v10.i28.10236.